Categories
Business & Finance homework help

FIRM VALUATION AND ETHICAL CONSIDERATIONS OF REFORMULATION

THE MEDFIELD PHARMA CASE: FIRM VALUATION AND ETHICAL CONSIDERATIONS OF REFORMULATION
Understand that the Medfield case has 2 major problems: 1) Firm Valuation – Impact of Patent Loss and Reformulation; 2) Ethical Considerations – How to Ensure Patients and third-party payees are not hurt
Organize your paper around the case questions. Use them as an organizing devise. This will benefit you in several ways: 1) provide a framework for constructing your paper; 2) ensure I (your reader) understand exactly what question you are answering; and 3) ensure you answer every question.
Use examples from Pfizer, AstraZeneca and other firms in EXHIBIT 3 to substantiate your thought.
What      is the current value of Medfield as a company? Use the exhibit 4      spreadsheet to calculate the NPV of Medfield. Compare this result to the      offer price and provide your reasoning for the difference.
If we      consider the sale of Medfield as the sale of existing assets how does the      elimination of R&D, investment in future assets, change the valuation      of Medfield? (Using the exhibit 4 spreadsheet distinguish between the NPV      value of existing products and R&D)
What      is the value that would be created by a reformulation? Complete and      explain the table below.
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Incremental Research
35
35
Incremental Special Marketing
25
25
25
25
25
Growth
2%
-50%
2%
2%
2%
2%
2%
2%
2%
2%
-50%
-50%
-50%
New Sales
214.77
Marginal Sales (New Sales – Original   Sales
0.00
New Cost of Sales
49.40
Marginal Cost of Sales
0.00
New Direct Marketing
57.99
Old Direct Marketing
57.99
59.15
29.57
14.79
7.39
0
0
0
0
0
0
0
0
0
Marginal Direct Marketing
0.00
New G&A
8.59
Old G&A
8.59
8.76
4.38
2.19
1.10
0
0
0
0
0
0
0
0
0
Marginal G&A
0.00
Marginal Cash Flow pre Tax
(60.00)
29.52
14.76
7.38
Marginal NOPAT
(40.80)
20.07
10.04
5.02
NPV
What      factors explain the value created from the reformulation for Fleximat?
Who      reaps the financial benefits?
Who      bears the financial costs?
ONLY ANSWER ONE OF THE QUESTION 7’S:
IF YOU SUPPORT REFORMULATION:
What      facts would change your mind and cause you to recommend against      reformulation?
IF YOU ARE AGAINST REFORMULATION
7. Under what conditions might you be in favor of reformulation?
How      would you change your thinking if Medfield’s reformulation approach were      more substantive (e.g. drug works faster, works longer) than cosmetic?
Could      Medfield use the extra value created by the reformulation to generate new and      helpful products?
When      you consider Medfield’s stakeholders, what are the key issues for each of      the following:
Shareholders       of Medfield
Patients       using the drug
Third-party       payees (Medicare, private insurance companies, etc.)
Government
Employees       of Medfield
Physicians
What      ethical issues need to be considered in making a reformulation decision?      Which are more pressing? Reference the ethics concepts discussed earlier      in the semester, include at least one of the Right vs. Wrong explanations      presented: Consequences, Duty, or Virtues. Use external references sources to support your discussion of the      ethical issues.
What      should Susan Johnson do? Explain      your choice of a, b, c, or d. If you have another approach, discuss it      here.
Don’t       pursue the reformulation, but accept takeover offer
Initiate       the reformulation and accept the offer
Refuse       the offer but initiate reformulation
Refuse       the offer and not reformulate
Your Turnitin Score needs to be 0-30% tops. Try to get it down there. If it is higher, I will read your paper, and see why the score is high but your grade will reflect the score.
REFERENCES MUST BE IN ALPHABETICAL ORDER. NAKED URLS ARE NOT ACCEPTABLE
APA conventions for citing and referencing:
https://owl.purdue.edu/owl/research_and_citation/apa_style/apa_formatting_and_style_guide/general_format.html//owl.purdue.